Browse > Article

Current Concept and Future of the Management of Spinal Cord Injury: A Systematic Review  

Choi, Il (Department of Neurological Surgery, Asan Medical Center, University of Ulsan, College of Medicine)
Ha, Jin Gyeong (Department of Neurological Surgery, Asan Medical Center, University of Ulsan, College of Medicine)
Jeon, Sang Ryong (Department of Neurological Surgery, Asan Medical Center, University of Ulsan, College of Medicine)
Publication Information
Journal of Trauma and Injury / v.26, no.3, 2013 , pp. 63-73 More about this Journal
Abstract
Spinal cord injury (SCI) is a serious condition associated with social and familial burden, as well as significant neurologic deficit. Despite the many advances in the treatment of spinal cord injury, a fundamental treatment for neurologic functional recovery has not yet been developed. In this article, we review two directions of development for spinal cord injury treatment: neuroprotective pharmacological agents and axon-regenerating cell therapy. We expect developments in these two to lead to improve functional recovery in patients with spinal cord injuries and to reduce burdens on society, as well as the patients' families.
Keywords
Cell therapy; Pharmacologic therapy; Spinal cord injuries; Stem cell;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991; 75: 15-26.   DOI
2 Hadley MN, Walters BC, Grabb PA, Oyesiku NM, Przybylski GJ, Resnick DK, et al. Guidelines for the management of acute cervical spine and spinal cord injuries. Clin Neurosurg 2002; 49: 407-98.
3 Fehlings MG, Louw D. Initial stabilization and medical management of acute spinal cord injury. Am Fam Physician 1996; 54: 155-62.
4 Baptiste DC, Fehlings MG. Update on the treatment of spinal cord injury. Prog Brain Res 2007; 161: 217-33.   DOI
5 Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007; 45: 206-21.   DOI   ScienceOn
6 Kim, Yun. Spinal cord injury. In: The Korean Spinal Neurosurgery Society, ed. The Textbook of Spine. Seoul: GunJa; 2008: 558-81.
7 Hurlbert RJ. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine (Phila Pa 1976) 2001; 26: S39- 46.   DOI   ScienceOn
8 Gregory W. J. Hawryluk, Fehlings MG. Current Status and Future Direction of Management of Spinal Cord Injury. In: H. Richard Winn M, ed. Youmans Neurological Surgery. philadephia: Elsevier Inc. ;2011: 2730-40.
9 Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N Engl J Med 2006; 355: 2376-8.   DOI   ScienceOn
10 Deda H, Inci MC, Kurekci AE, Kayihan K, Ozgun E, Ustunsoy GE, et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008; 10: 565-74.   DOI   ScienceOn
11 Saberi H, Moshayedi P, Aghayan HR, Arjmand B, Hosseini SK, Emami-Razavi SH, et al. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 2008; 443: 46-50.   DOI   ScienceOn
12 Sykova E, Homola A, Mazanec R, Lachmann H, Konradova SL, Kobylka P, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15: 675-87.   DOI   ScienceOn
13 Callera F, do Nascimento RX. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol 2006; 34: 130-1.   DOI   ScienceOn
14 Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine 2005; 3: 173-81.   DOI   ScienceOn
15 Ankeny DP, McTigue DM, Jakeman LB. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol 2004; 190: 17-31.   DOI   ScienceOn
16 Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000; 11: 3001-5.   DOI   ScienceOn
17 Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002; 99: 2199-204.   DOI   ScienceOn
18 Wu S, Suzuki Y, Ejiri Y, Noda T, Bai H, Kitada M, et al. Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res 2003; 72: 343-51.   DOI   ScienceOn
19 Park HC, Shim YS, Ha Y, Yoon SH, Park SR, Choi BH, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005; 11: 913-22.   DOI   ScienceOn
20 Callera F, de Melo CM. Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site. Stem Cells Dev 2007; 16: 461-6.   DOI   ScienceOn
21 Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda- Kurkalli B, Gomori JM, Kassis I, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010; 67: 1187-94.
22 Obenaus A, Dilmac N, Tone B, Tian HR, Hartman R, Digicaylioglu M, et al. Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury. Ann Neurol 2011; 69: 282-91.   DOI   ScienceOn
23 Samdani AF, Paul C, Betz RR, Fischer I, Neuhuber B. Transplantation of human marrow stromal cells and mononuclear bone marrow cells into the injured spinal cord: a comparative study. Spine (Phila Pa 1976) 2009; 34: 2605-12.   DOI   ScienceOn
24 Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 2007; 104: 10211-6.   DOI   ScienceOn
25 Gonzalez-Lara LE, Xu X, Hofstetrova K, Pniak A, Chen Y, McFadden CD, et al. The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury. Mol Imaging Biol 2011; 13: 702-11.   DOI   ScienceOn
26 Himes BT, Neuhuber B, Coleman C, Kushner R, Swanger SA, Kopen GC, et al. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair 2006; 20: 278-96.   DOI   ScienceOn
27 Wright KT, Masri WE, Osman A, Chowdhury J, Johnson WEB. Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical Applications. STEM CELLS 2011; 29: 169-78.   DOI   ScienceOn
28 Dasari VR, Spomar DG, Cady C, Gujrati M, Rao JS, Dinh DH. Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res 2007; 32: 2080-93.   DOI
29 Bakshi A, Barshinger AL, Swanger SA, Madhavani V, Shumsky JS, Neuhuber B, et al. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: a novel method for minimally invasive cell transplantation. J Neurotrauma 2006; 23: 55-65.   DOI   ScienceOn
30 Ohta M, Suzuki Y, Noda T, Ejiri Y, Dezawa M, Kataoka K, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004; 187: 266-78.   DOI   ScienceOn
31 Saito F, Nakatani T, Iwase M, Maeda Y, Hirakawa A, Murao Y, et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma 2008; 64: 53-9.   DOI   ScienceOn
32 Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 2007; 25: 2066-73.   DOI   ScienceOn
33 Pal R, Gopinath C, Rao NM, Banerjee P, Krishnamoorthy V, Venkataramana NK, et al. Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 2010; 12: 792-806.   DOI   ScienceOn
34 Kishk NA, Gabr H, Hamdy S, Afifi L, Abokresha N, Mahmoud H, et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 2010; 24: 702-8.   DOI
35 Vazin T, Freed WJ. Human embryonic stem cells: derivation, culture, and differentiation: a review. Restor Neurol Neurosci 2010; 28: 589-603.
36 Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008; 132: 661-80.   DOI   ScienceOn
37 Kim SU. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004; 24: 159-71.   DOI   ScienceOn
38 Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006; 82: 865-75.
39 Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213: 341-7.   DOI   ScienceOn
40 Verma A, Verma N. Induced pluripotent stem cells and promises of neuroregenerative medicine. Neurol India 2011; 59: 555-7.   DOI
41 Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, et al. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 2010; 1343: 226-35.   DOI   ScienceOn
42 Erceg S, Ronaghi M, Stojkovic M. Human embryonic stem cell differentiation toward regional specific neural precursors. Stem Cells 2009; 27: 78-87.   DOI   ScienceOn
43 Ronaghi M, Erceg S, Moreno-Manzano V, Stojkovic M. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 2010; 28: 93-9.
44 Li JY, Christophersen NS, Hall V, Soulet D, Brundin P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 2008; 31: 146-53.   DOI   ScienceOn
45 Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002; 22: 6623-30.
46 Lima C, Escada P, Pratas-Vital J, Branco C, Arcangeli CA, Lazzeri G, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair 2010; 24: 10-22.   DOI   ScienceOn
47 Huang H, Chen L, Wang H, Xiu B, Li B, Wang R, et al. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl) 2003; 116: 1488-91.
48 Huang H, Wang H, Chen L, Gu Z, Zhang J, Zhang F, et al. Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2006; 20: 434-8.
49 Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med 2006; 29: 191-203; discussion 4-6.
50 Saberi H, Firouzi M, Habibi Z, Moshayedi P, Aghayan HR, Arjmand B, et al. Safety of intramedullary Schwann cell trans-plantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases. J Neurosurg Spine 2011; 15: 515-25.   DOI   ScienceOn
51 Bhanot Y, Rao S, Ghosh D, Balaraju S, Radhika CR, Satish Kumar KV. Autologous mesenchymal stem cells in chronic spinal cord injury. Br J Neurosurg 2011; 25: 516-22.   DOI   ScienceOn
52 Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011; 28: 1611-82.   DOI   ScienceOn
53 Park JH, Kim DY, Sung IY, Choi GH, Jeon MH, Kim KK, et al. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 2012; 70: 1238-47; discussion 47.   DOI   ScienceOn
54 Saito F, Nakatani T, Iwase M, Maeda Y, Murao Y, Suzuki Y, et al. Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study. Restor Neurol Neurosci 2012; 30: 127-36.
55 Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, et al. Ex vivo-expanded autologous bone marrowderived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 2009; 11: 897-911.   DOI   ScienceOn
56 Pehar M, Vargas MR, Robinson KM, Cassina P, England P, Beckman JS, et al. Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons. Free Radic Biol Med 2006; 41: 1632-44.   DOI   ScienceOn
57 Baptiste DC, Fehlings MG. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 2006; 23: 318-34.   DOI   ScienceOn
58 Pitts LH, Ross A, Chase GA, Faden AI. Treatment with thyrotropin- releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma 1995; 12: 235-43.   DOI   ScienceOn
59 Petitjean ME, Pointillart V, Dixmerias F, Wiart L, Sztark F, Lassie P, et al. [Medical treatment of spinal cord injury in the acute stage]. Ann Fr Anesth Reanim 1998; 17: 114-22.   DOI   ScienceOn
60 Cafferty WB, Bradbury EJ, Lidierth M, Jones M, Duffy PJ, Pezet S, et al. Chondroitinase ABC-mediated plasticity of spinal sensory function. J Neurosci 2008; 28: 11998-2009.   DOI   ScienceOn
61 Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 1998; 95: 15769-74.   DOI   ScienceOn
62 Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008; 25: E2.
63 Kojima A, Tator CH. Epidermal growth factor and fibroblast growth factor 2 cause proliferation of ependymal precursor cells in the adult rat spinal cord in vivo. J Neuropathol Exp Neurol 2000; 59: 687-97.
64 Wells JE, Hurlbert RJ, Fehlings MG, Yong VW. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003; 126: 1628-37.   DOI   ScienceOn
65 Bhatt JM, Gordon PH. Current clinical trials in amyotrophic lateral sclerosis. Expert Opin Investig Drugs 2007; 16: 1197-207.   DOI   ScienceOn
66 Mu X, Azbill RD, Springer JE. Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J Neurotrauma 2000; 17: 773-80.   DOI   ScienceOn
67 J B. The Edwin Smith surgical papyrus. In: R W, ed. Neurosurgical classics. New York Johnson Reprint Corp. ; 1965: 1-5.
68 Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001; 24: 254-64.   DOI   ScienceOn
69 Balentine JD. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest 1978; 39: 236-53.
70 Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999; 44: 1027-39; discussion 39-40.   DOI   ScienceOn
71 Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 2008; 17: 1277-93.   DOI   ScienceOn
72 Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-11.   DOI   ScienceOn
73 Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.   DOI   ScienceOn